|
OMEGA-3 INGREDIENTS · PRODUCT DEVELOPMENT Fish Oil Is Not the Whole Omega‑3 StoryFish oil, algal oil, krill oil and ALA-rich plant oils can share a category without delivering the same fatty acids—or the same product story. |
Fish oil may be the best-known omega-3 ingredient, but it is not a synonym for omega-3. Fish oil, algal oil, krill oil and ALA-rich plant oils can all sit under the same category while delivering different fatty acids, molecular forms and formulation challenges.
That distinction matters commercially. A heart-health product, DHA-led concept, vegan formula or phospholipid story may require a different ingredient—even when every front label says “omega-3.”
FATTY-ACID FIRST
Start With the Fatty Acid, Not the Source Story
The three names buyers meet most often are alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). ALA is essential and is commonly supplied by flaxseed, chia, soybean and canola oils. The body can convert ALA to EPA and then DHA, but the conversion is limited; the US National Institutes of Health reports rates below 15%. ALA should therefore not be treated as a milligram-for-milligram substitute for preformed EPA and DHA. [1]
EPA and DHA are the long-chain omega-3s most frequently used in marine-oil supplements. In the European Union, authorised claims distinguish them: 250 mg/day EPA+DHA supports the normal function of the heart, while 250 mg/day DHA supports maintenance of normal brain function and vision, subject to the applicable conditions of use. [2]
The better question is not “Which omega-3 is best?” It is “Which fatty-acid profile fits the intended product and permitted claim?”
FOUR SOURCES, FOUR PRODUCT BRIEFS
The Front Label May Look Similar. The Formulation Is Not.
|
01 · FISH OIL EPA + DHA Ratios vary by species and concentration. Commercial grades may use natural triglyceride, ethyl-ester or re-esterified triglyceride forms. |
02 · ALGAL OIL Often DHA-led Some grades also provide EPA. It can support vegetarian or vegan positioning where the ingredient and market requirements allow. |
|
03 · KRILL OIL EPA + DHA in phospholipids Colour, odour, phospholipid content and achievable payload must be considered; category-wide absorption superiority is not established. |
04 · PLANT OILS Primarily ALA A plant-based omega-3 proposition, but not a direct EPA+DHA replacement on a milligram-for-milligram basis. |
These are category patterns, not universal specifications. Actual fatty-acid profiles and molecular forms must be confirmed from the proposed grade and test method.
Source choice should follow the target fatty-acid profile, dosage, format and destination market—not the ingredient story alone.
DOSE REALITY
A 1,000 mg Capsule May Not Deliver 1,000 mg of Omega-3
“1,000 mg fish oil” describes the oil fill, not necessarily the EPA+DHA content. A conventional oil might supply 180 mg EPA and 120 mg DHA per gram, while concentrated grades can deliver substantially more. Codex defines concentrated fish oil as containing 35–50% EPA+DHA and highly concentrated fish oil as containing more than 50%, although the exact commercial specification still needs to state the assay basis and method. [1,3]
THE NUMBER BUYERS SHOULD NOT CONFUSE
1,000 mg oil ≠ 1,000 mg EPA + DHA
Compare the following on the same basis:
| ● | EPA, DHA and total omega-3 per gram of oil |
| ● | The daily serving rather than capsule count alone |
| ● | Triglyceride, re-esterified triglyceride, ethyl-ester or phospholipid form |
| ● | Calculation basis, method, capsule fill and realistic daily unit count |
FRESHNESS AND QUALITY
Freshness Can Matter More Than the Source Hierarchy
All long-chain polyunsaturated oils are vulnerable to oxidation. For most fish oils covered by Codex CXS 329-2017, the reference limits are peroxide value no more than 5 meq active oxygen/kg, anisidine value no more than 20 and TOTOX no more than 26. TOTOX is calculated as 2 × peroxide value + anisidine value. [3]
| PEROXIDE VALUE≤ 5meq active oxygen/kg | ANISIDINE VALUE≤ 20Codex reference | TOTOX≤ 262 × PV + AV |
Important boundary
Codex treats high-phospholipid oils such as krill oil differently. Ordinary anisidine and TOTOX limits should not be copied blindly across every omega-3 ingredient.
Oxidation data should be interpreted with the oil matrix, analytical method, packaging and shelf-life plan.
PRODUCT FIT
Choose the Ingredient After Defining the Product
Fish oil may suit a cost-efficient EPA+DHA product. A DHA-rich algal oil may fit a vegan or DHA-led concept. Krill oil may support a differentiated phospholipid format, while an ALA-rich plant oil serves a different nutritional proposition rather than imitating marine EPA+DHA.
SRS Nutrition Express can provide available omega-3 specifications, representative COAs and sample options for technical evaluation. Share the target EPA and DHA per serving, preferred molecular form, capsule size, destination market and annual volume so that suitable options can be compared on the same basis.
EVIDENCE BOUNDARIES
Do Not Turn a Source Difference Into a Universal Superiority Claim
- No omega-3 source is universally superior for every consumer or product.
- ALA is nutritionally relevant but should not be equated directly with EPA+DHA exposure.
- Bioavailability depends on molecular form, meal conditions, dose and study design.
- Authorised health claims and conditions of use vary by market.
- Codex values do not replace destination-market rules or an approved buyer specification.
Planning an Omega-3 Product?
Share your target EPA and DHA, preferred source and molecular form, dosage format, destination market and estimated volume.
References
- US National Institutes of Health, Office of Dietary Supplements. Omega-3 Fatty Acids: Fact Sheet for Health Professionals.
- European Commission. Commission Regulation (EU) No 432/2012.
- Codex Alimentarius Commission. Standard for Fish Oils, CXS 329-2017, amended 2024.
Post time: Sep-25-2026
